The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - CBT Pharmaceuticals
Leadership - CBT Pharmaceuticals
Stock and Other Ownership Interests - CBT Pharmaceuticals
Activity of CBT-501, a novel humanized anti-PD-1 antibody, in a humanized genetically engineered mouse model of colon carcinoma.
 
Qing Zhou
Employment - Genor BioPharma
Leadership - Genor Biopharma
Stock and Other Ownership Interests - Walvax Biotechnology
Research Funding - Genor BioPharma
Patents, Royalties, Other Intellectual Property - Genor Biopharma
Travel, Accommodations, Expenses - Genor Biopharma
 
Weihong Nian
Employment - Genor BioPharma
Leadership - Genor BioPharma
Stock and Other Ownership Interests - Genor BioPharma
Research Funding - Genor BioPharma
Patents, Royalties, Other Intellectual Property - Genor BioPharma
Travel, Accommodations, Expenses - Genor BioPharma
 
Ziyong Sun
Employment - Crown Bioscience
 
Junzhuan Qiu
Employment - Crown Bioscience
 
Zhun Wang
Employment - Crown Bioscience
 
Gavin Choy
No Relationships to Disclose
 
Sanjeev Redkar
Employment - CBT Pharmaceuticals
Leadership - CBT Pharmaceuticals
Stock and Other Ownership Interests - CBT Pharmaceuticals